文献速递头痛与眩晕

维生素D补充预防良性阵发性位置性眩晕复发的随机试验

Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: A randomized trial.
PubMed 文献 · Neurology · 2020-08-05

意向性分析显示干预组年复发率降低(0.83 vs 1.10次/人年), incidence rate ratio 0.76,需治疗人数3.70。结论认为对频繁发作且血清维生素D偏低的BPPV患者可考虑补充维生素D和钙。

要点

  • BPPV复位成功后补充维生素D和钙可降低年复发率。
  • 干预组复发比例37.8%低于观察组46.7%。
  • 需治疗人数为3.70,提示临床获益明显。

核心结论

  • 对频繁发作的BPPV患者,尤其血清维生素D低于20 ng/mL时,可考虑补充维生素D和钙以预防复发。

研究设计与样本

  • 确诊BPPV患者经复位手法成功治疗后随机分为干预组518例和观察组532例。

主要发现

  • 干预组年复发率为0.83(95%CI 0.74-0.92)次/人年,观察组为1.10(95%CI 1.00-1.19)次/人年。
  • 发病率比为0.76(95%CI 0.66-0.87,p<0.001),绝对率比为-0.27(-0.40至-0.14)。
  • 需治疗人数为3.70(95%CI 2.50-7.14)。
  • 干预组复发患者比例为37.8%,观察组为46.7%(p=0.005)。

关键数值与推荐

  • 干预组在血清维生素D低于20 ng/mL时服用维生素D 400 IU和碳酸钙500 mg,每日两次,共1年。
  • 观察组仅随访,不进行维生素D评估或补充。

临床怎么用

  • 对频繁发作的BPPV患者,可检测血清维生素D,低于20 ng/mL时考虑补充维生素D和钙。
  • 补充方案为维生素D 400 IU和碳酸钙500 mg每日两次,持续1年。

局限性

  • 研究提供Class III证据,证据等级有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of vitamin D and calcium supplementation in preventing recurrences of benign paroxysmal positional vertigo (BPPV). METHODS: We performed an investigator-initiated, blinded-outcome assessor, parallel, multicenter, randomized controlled trial in 8 hospitals between December 2013 and May 2017. Patients with confirmed BPPV were randomly assigned to the intervention (n = 518) or the observation (n = 532) group after successful treatment with canalith repositioning maneuvers. The primary outcome was the annual recurrence rate (ARR). Patients in the intervention group had taken vitamin D 400 IU and 500 mg of calcium carbonate twice a day for 1 year when serum vitamin D level was lower than 20 ng/mL. Patients in the observation group were assigned to follow-ups without further vitamin D evaluation or supplementation. RESULTS: The intervention group showed a reduction in the ARR (0.83 [95% confidence interval (CI), 0.74-0.92] vs 1.10 [95% CI, 1.00-1.19] recurrences per 1 person-year) with an incidence rate ratio of 0.76 (95% CI, 0.66-0.87, p < 0.001) and an absolute rate ratio of -0.27 (-0.40 to -0.14) from intention-to-treat analysis. The number needed to treat was 3.70 (95% CI, 2.50-7.14). The proportion of patients with recurrence was also lower in the intervention than in the observation group (37.8 vs 46.7%, p = 0.005). CONCLUSIONS: Supplementation of vitamin D and calcium may be considered in patients with frequent attacks of BPPV, especially when serum vitamin D is subnormal. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with BPPV, vitamin D and calcium supplementation reduces recurrences of BPPV.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Jeong SH, Kim JS, Kim HJ, et al. Prevention of benign paroxysmal positional vertigo with vitamin D supplementation: A randomized trial. Neurology. 2020. PMID: 32759193. doi:10.1212/WNL.0000000000010343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。